Zurueck zur Suche

Reporte zur Charge U76658A

Verknuepft ueber VAERS_ID mit VAERSDATA, Vax und Symptoms

4Reporte angezeigt
0Todesfaelle
0Hospitalisiert
0Lebensbedrohlich
0Bleibende Schaeden
VA 2 FL 1 AZ 1

VAERS 2647007

SANOFI PASTEUR · TDAP (ADACEL) · Charge u76658a

schwer
Staat
FL
Alter
26,0
Geschlecht
M
Eingang
19.06.2023
Impfdatum
19.06.2023
Beginn
19.06.2023
Tage bis Beginn
0,0
Dosis
1
Route/Site
IM / RA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Syncope

Symptomtext

patient fainted after giving last vaccination -Adacel. Patient was quickly revived in a few seconds. We checked his blood pressure 102/67-pulse92. We had patient remain in pharmacy for 30 minutes to monitor him. He said he was fine and went home.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Syncope
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
unknown
Vorgeschichte
none
Andere Medikamente
unknown
Allergien
none
Vorherige Impfungen
pt said he always faints after vaccines

VAERS 2677152

SANOFI PASTEUR · TDAP (ADACEL) · Charge U76658A

mild
Staat
AZ
Alter
39,0
Geschlecht
M
Eingang
28.08.2023
Impfdatum
22.08.2023
Beginn
26.08.2023
Tage bis Beginn
4,0
Dosis
UNK
Route/Site
IM / RA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: nein
Flank pain Injection site swelling Lymphadenopathy Pain

Symptomtext

Injection site swollen, pain radiating down his R flank, swollen lymph notes under R arm

Weitere VAERSDATA-Felder
Praegender Schweregrund
Flank pain
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
On Home O2 secondary to post COVID 19
Vorgeschichte
DM
Andere Medikamente
Unknown
Allergien
Vancomycin
Vorherige Impfungen
-

VAERS 2632743

SANOFI PASTEUR · TDAP (ADACEL) · Charge U76658A

gering
Staat
VA
Alter
12,0
Geschlecht
F
Eingang
17.05.2023
Impfdatum
05.05.2023
Beginn
05.05.2023
Tage bis Beginn
0,0
Dosis
UNK
Route/Site
OT / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Poor quality product administered Product storage error

Symptomtext

patient received adacel after it experienced a temperature excursion, with no reported adverse event; Initial information received on 10-May-2023 regarding an unsolicited valid non-serious case received from a pharmacist. This case involves a 12 years old female patient who received vaccine Diphtheria-2/Tetanus/5 AC Pertussis Vaccine [Adacel] after it experienced a temperature excursion, with no reported adverse event. The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided. Concomitant medications included Meningococcal Vaccine A/C/Y/W CONJ (Crm197) (Menveo) and Tozinameran (Pfizer Biontech Covid-19 Vaccine) for Immunisation. On an unknown date temperature excursion happened, on 05-May-2023, the patient received ADACEL was after temperature excursion that was not supported at a dose 0.5 ml (1x) total of suspect Diphtheria-2/Tetanus/5 AC Pertussis Vaccine suspension for injection (lot: U76658A, Expiry date: 04-Mar-2025) via unknown route in unknown administration site for Immunisation (poor quality product administered) (latency: same day). Action taken: not applicable. At time of reporting, the outcome was Unknown. This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holder's compliance with the requirements set out in the guidelines. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Poor quality product administered
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2632256

SANOFI PASTEUR · TDAP (ADACEL) · Charge U76658A

gering
Staat
VA
Alter
8,0
Geschlecht
F
Eingang
16.05.2023
Impfdatum
05.05.2023
Beginn
05.05.2023
Tage bis Beginn
0,0
Dosis
UNK
Route/Site
OT / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
No adverse event Product storage error

Symptomtext

medication error due to ADACEL was administered after a temperature excursion that was not supported (with no reported adverse event); medication error due to ADACEL was administered after a temperature excursion that was not supported (with no reported adverse event); Initial information was received on 10-May-2023 regarding an unsolicited valid non-serious case received from a pharmacist. This case involves a 8 years old female patient who reported medication error due to DIPHTHERIA-2/TETANUS/5 AC PERTUSSIS VACCINE [ADACEL] was administered after a temperature excursion that was not supported (with no reported adverse event). The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided. On 05-May-2023, the patient received a 0.5 ml dose, Total (once) of suspect DIPHTHERIA-2/TETANUS/5 AC PERTUSSIS VACCINE (Suspension for injection) (lot number: U76658A , expiry date: 04-Mar-2025, strength: standard) via unknown route in unknown administration site for prophylactic vaccination. On an unknown date the patient had medication error due to adacel was administered after a temperature excursion that was not supported (with no reported adverse event) (product storage error) (unknown latency) following the administration of DIPHTHERIA-2/TETANUS/5 AC PERTUSSIS VACCINE. On 05-MAY-2023 the patient had medication error due to adacel was administered after a temperature excursion that was not supported (with no reported adverse event) (poor quality product administered) same day following the administration of DIPHTHERIA-2/TETANUS/5 AC PERTUSSIS VACCINE. Action taken: not applicable. It was not reported if the patient received a corrective treatment for the events. At time of reporting, the outcome was Unknown for the event. This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holder's compliance with the requirements set out in the Directive 2001/83/EC and Module VI of the Good Pharmacovigilance Practices. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.

Weitere VAERSDATA-Felder
Praegender Schweregrund
No adverse event
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-